ContraFect (NASDAQ:CFRX) Receives New Coverage from Analysts at StockNews.com

StockNews.com started coverage on shares of ContraFect (NASDAQ:CFRX – Free Report) in a report released on Saturday. The firm issued a sell rating on the biotechnology company’s stock. ContraFect Stock Performance Shares of NASDAQ CFRX opened at $0.05 on Friday. The firm has a market cap of $535,000.00, a P/E ratio of 0.00 and a […]

Related Keywords

United States , ,Virtu Financial ,Armistice Capital ,Contrafect Corporation ,Renaissance Technologies ,Goldman Sachs Group Inc ,Free Report ,Get Free Report ,Sigma Investments ,Goldman Sachs Group ,Sachs Group ,Fect Corporation ,Contrafect Daily ,Contrafect ,Nasdaq Cfrx ,Cfrx ,Medical ,Initiated Coverage ,Stocknews Com ,